K2 partners with University and Academic Medical Centers (UAMC) in order to finance and progress their internal discoveries, innovations, and startup companies.
The K2 vision is to create a portfolio of selected UAMC optioned and licensed assets that access centralized resources and management teams.
The development, commercialization, and company management activities are performed by K2 and its team of biotech and industry executives until adequate valuations justify external investment or acquisition.
K2 has developed a discipline for commercial evaluation and assessment of early discoveries and is applying its capabilities and processes for portfolio management to progress discoveries through preclinical proof of concept and regulatory submissions.
In parallel, K2 is establishing a financial market attracted to the de-risking and value creation resulting from the rapid, efficient development and commercialization of a portfolio of UAMC innovations.
K2 is dedicated to aligning with the missions of the University and Academic Medical Centers with which it partners.
The K2 vision is to create a portfolio of selected UAMC optioned and licensed assets that access centralized resources and management teams.
The development, commercialization, and company management activities are performed by K2 and its team of biotech and industry executives until adequate valuations justify external investment or acquisition.
K2 has developed a discipline for commercial evaluation and assessment of early discoveries and is applying its capabilities and processes for portfolio management to progress discoveries through preclinical proof of concept and regulatory submissions.
In parallel, K2 is establishing a financial market attracted to the de-risking and value creation resulting from the rapid, efficient development and commercialization of a portfolio of UAMC innovations.
K2 is dedicated to aligning with the missions of the University and Academic Medical Centers with which it partners.